Biotech group strikes Middle East and Africa distribution deal
Yourgene Health is launching a distribution partnership with Dubai-based Alliance Global across a broad range of territories in the Middle East and Africa to expand the company’s geographical footprint and its customer base.
Alliance Global is the largest biomedical gateway in the Middle East, Africa, and Asia and is both a well-respected and a long-term partner for many international and US diagnostics groups looking to pursue a strategy of expansion in these regions.
It is dedicated to bringing innovative technologies and products to researchers, clinicians, and diagnostic users in the regions’ emerging healthcare market, and is a well positioned platform agnostic partner for the Manchester-based biotech specialist, working with key providers of both PCR and sequencing technologies.
AGBL will be focusing on Yourgene’s product portfolio of non-invasive prenatal testing (NIPT), the reproductive health range including Cystic Fibrosis and QST*R rapid aneuploidy analysis, DPYD genotyping and the new size selection and enrichment technologies, Yourgene QS250 and LightBench.
In response to the restriction on travel to key regions as a result of the COVID-19 pandemic, Yourgene has reviewed its strategy for bringing products to market in new territories.
Following a review of the company’s channels across its international markets, the commitment and focus with a local network in the Middle East and Africa provided by AGBL is expected to generate future growth opportunities for the company.
AGBL has strong technical expertise to distribute and support Yourgene’s growing product range and customer base across these regions, offering an expansive geographic reach and more commercial drivers on the ground to meet the needs of this exciting, emerging international market.
Lyn Rees, Yourgene chief executive, said: “This partnership with AGBL is a really exciting progression for Yourgene and our product portfolio as we continue to expand into further territories.
“AGBL will provide a strong and well positioned channel to allow us to deliver and drive growth for our current and future products.”
He added: “This is a key international market for Yourgene and we look forward to working with AGBL and utilising their expertise to secure further market penetration and geographic expansion.”
